Anti-coags Flashcards

1
Q

What are the 4 oral anti-platelet drugs?

A

Aspirin, clopidogrel, Ticgrelor, dipyridamole + ASA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ASA MOA?

A

Irreversibly acetylates COX, preventing platelet syn of TXA2 and thus platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

3 non-cardio uses of ASA?

A

anti-pyretic, analgesic, anti-inflamm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

PK of ASA?

A

half = 2-3 hours; Tx effect = 7-10 days (life of platelet)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MOA of clopidogrel and ticagrelor? Difference?

A

Antagonist of ADP receptor P2Y12 on platelets - prevents ADP induced cAMP decrease and subsequent aggregation
C is irreversible, T is reversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Half life and metabolism of clopidogrel?

A
  • t1/2 = 7-10 days (irreversible)

- CYP2C19 pro-drug metal (some are ‘slow’ metabolizers, inhibited by omeprazole)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Half life and metab of ticagrelor?

A
  • active drug
  • 7 hours (9 for active metabolite)
  • CYP3A metabolism (watch for inducers, inhibitors)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MOA of dipyridamole? Why combine with ASA?

A
  • blocks adenine uptake, inhibits phoshodiesterase (increased cAMP, decreased aggregation, vasodilation)
  • not very effective alone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What anti-platelet drug is parenteral?

A

Abciximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dual f(x)/MOA of Abciximab?

A
  • antagonist of GP IIb/IIIa – prevents fibrinogen and vWF from binding platelets
  • prevents PT binding to platelets, decreasing thrombin formed = ANTI-COAG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Half life of abciximab?

A
free drug = 30 min
bound drug = 18-24 hours
platelet f(x) returns in 48 hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the parenteral anti-coagulants?

A

Heparin, enoxaparin, fondaparinux, bivalirudin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does UFH work?

A

Complexes with AT, increasing its activity – inactivation of IIa, IXa, Xa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is UFH administered?

A

IV or SC - large molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Half life of heparin? Monitoring?

A

DOSE DEPENDENT - 30-150 min

Must monitor using aPTT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Three AE’s of heparin?

A
  • HI thrombocytopenia
  • heparin hypersensitivity
  • osteoporosis
17
Q

Heparin antidote?

A

protamine sulfate

18
Q

What kind of drug is enoxaparin?

A
  • LMWH

- complexes AT increasing its activity – inactivates Xa ONLY

19
Q

How do LMWH’s compare to UFH pharmacokinetically?

A
  • longer t1/2 = 3-6 hours
  • equally efficacious
  • greater SC bioavailability (fewer doses)
  • more predictable levels/PK - Xa monitoring not required
20
Q

What is fondaparniux? Administration? Metabolism?

A
  • synthetic heparin-like pentasaccharide
  • SC
  • t1/2 = 17 HOURS 1x day injection
21
Q

aPTT therapeutic goal in heparin Tx?

A

2-3x patient’s normal aPTT

22
Q

Bivalirudin MOA and metabolism?

A

direct irreversible inhibition of circulating and clot-bound thrombin

IV infusion t1/2 = 25 MINUTES

23
Q

When is bivalirudin indicated?

A

Pt’s who require hep but have had HIT; microvascular surgery to re-attach digits

24
Q

Which coag factors depend on Vitamin K?

A

2, 7, 9, 10, C, S

25
Warfarin MOA and onset?
- inhibits Vit K epoxide reductase | - onset observed in 8-12 hours; full effect in 3 days
26
Warfarin administration and metabolism?
- PO | - long plasma half-life, highly plasma protein bound, hepatic metab via VARIOUS CYPS (many interactions)
27
Four AE's of warfarin?
- bleeding - skin necrosis due to early imbalance of pro/anti coag factors - purple toe syndrome (cholesterol microemboli) - teratogen cat X
28
Warfarin antidotes?
- Vit K, FFP, PT complex or recombinant VIIa
29
Advantages of Dabigatran over Warfarin?
direct action on II, no CYP450 interactions, more effective with fewer interactions
30
Dabigatran MOA?
competitive inhibitor of thrombin activity on both fibrinogen and platelets decreasing both coag and platelet activity; PO
31
Dabigatrain metabolism? Half life? Special dosing considerations?
- prodrug cleaved by esterases and glucuroniated without CYP450 activity - 14 HOURS = LONG - dose adjustment needed in RENAL DISEASE
32
How does Rivaroxaban work? Administration?
DIRECTLY inhibits Xa; oral 1x day t1/2 = 9 hours LONG
33
Metabolism and administration of Alteplase tPA?
IV ONLY; t 1/2 = 5-10 minutes
34
How does tPA work?
binds fibrin and converts plasminogen to plasmin permitting clot degradation
35
Fibrinolytic antidote?
Epsilon aminocaproic acid, PO, IV tranxenamic acid -- inhibits plasminogen activation